Program Goals
The purpose of this program is to review the current understanding of the biological, behavioral, and clinical implications of female sex/gender on lung and sleep health disease, and to propose clinical approaches for achieving better health outcomes through more precise management of female patients with lung disease. The activity will inform physicians and advanced practitioners about the importance of considering sex and gender when evaluating patients with pulmonary disease, with sex being a biological construct and gender encompassing not just biology but
also social and environmental factors that may influence disease presentation, diagnosis, progression and treatment.
Target Audience
The educational design of this activity addresses the needs of everyone in the healthcare facilities specifically;pulmonologists, critical care specialists, thoracic surgeons, radiologists, internal medicine and primary care physicians, physician assistants, advanced practice nurses, and nurse practitioners.
Learning Objectives
After completion of this activity participants will be able to:
- Analyze pulmonary disease burden among women.
- Describe how gender may influence pulmonary disease presentation and progression.
- Recognize clinical implications of gender differences in pulmonary disease.
- Explain differences in risk for pulmonary vascular disease between men and women.
- Describe sex-based differences in treatment responses in pulmonary arterial hypertension.
- Discuss resiliency to disease progression in women with established pulmonary arterial hypertension.
Speakers
MeiLan K. Han, MD MS
Professor of Medicine and Chief of the Division of Pulmonary
and Critical Care at the University of Michigan
Anna R. Hemnes, MD
Associate Professor of Medicine, Division of Allergy, Pulmonary and
Critical Care Medicine, Vanderbilt University Medical Center
Partner
Dane Garvin
Gender Differences in Respiratory Care References
Accreditation Statement
This activity is provided by MEDtalks
Physician Accreditation Statement - EACCME
MEDtalks is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
Physician Credit Designation - EACCME
MEDtalks designates this enduring material for a maximum of 1.0 UEMS Credits™. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited. Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
